15
Participants
Start Date
March 11, 2013
Primary Completion Date
April 4, 2017
Study Completion Date
January 31, 2021
Oxymorphone hydrochloride (HCl)
Opioid
Endo Clinical Trial Site #4, Pittsburgh
Endo Clinical Trial Site #2, Nashville
Endo Clinical Trial Site #5, New Orleans
Endo Clinical Trial Site #1, Oklahoma City
Endo Clinical Trial Site #3, Orange
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY